Geisinger Clinic | Geisinger Danville - Anesthesiology
Status and phase
Conditions
Treatments
About
The purpose of this study was to evaluate the safety and efficacy of once daily subcutaneous (SC) administration of setmelanotide in participants with obesity and specific gene variants in the MC4R pathway.
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Key Inclusion Criteria:
Key Exclusion Criteria:
Other protocol defined Inclusion/Exclusion criteria applied.
Primary purpose
Allocation
Interventional model
Masking
164 participants in 3 patient groups, including a placebo group
Loading...
Central trial contact
Physician Inquiry: Clinical Trials; Rhythm Clinical Trials
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal